We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about the different types of Non-Small Cell Lung Cancer (NSCLC), including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Understand symptoms, diagnosis, treatment options, and prevention strategies for this common lung cancer.

Non-Small Cell Lung Cancer (NSCLC) is the most prevalent form of lung cancer, accounting for a significant majority of all lung cancer diagnoses. It arises when abnormal cells in the lungs begin to grow uncontrollably, forming tumors. Unlike Small Cell Lung Cancer (SCLC), NSCLC generally grows and spreads more slowly. Understanding the different types of NSCLC is crucial as each subtype can have distinct characteristics, influencing prognosis and treatment strategies. This article aims to provide a comprehensive overview of NSCLC, covering its main types, common symptoms, diagnostic methods, treatment options, and preventive measures, tailored for an Indian audience.
NSCLC is broadly categorized into three main types, with a few rarer subtypes also existing. The primary types are:
Adenocarcinoma is the most common type of NSCLC, making up about 40% of all lung cancers. It originates in the cells that produce mucus and other substances, typically found in the outer parts of the lungs. A notable characteristic of adenocarcinoma is that it can affect individuals who have never smoked, although it is still more common among smokers and former smokers. It is also the type of lung cancer most frequently diagnosed in younger people and women.
Squamous cell carcinoma accounts for approximately 25-30% of NSCLC cases. This type develops from flat, thin cells called squamous cells that line the inside of the airways. It is often found in the central part of the lungs, near the main airways (bronchi). Smoking is the most significant risk factor for squamous cell carcinoma. It is less common in non-smokers compared to adenocarcinoma.
Large cell carcinoma, also known as undifferentiated carcinoma, represents about 10-15% of NSCLC cases. This type can appear in any part of the lung and tends to grow and spread more rapidly than the other two main types. Its large, abnormal-looking cells are visible under a microscope. Large cell carcinoma can be more challenging to treat and is more commonly seen in men.
In addition to the main types, there are rarer forms of NSCLC, including:
The symptoms of NSCLC can vary depending on the type, size, and location of the tumor, as well as whether it has spread. Many symptoms may not appear until the cancer is advanced. Common signs and symptoms include:
Diagnosing NSCLC involves a multi-step process to confirm the presence of cancer, determine its type, and assess its stage (how far it has spread). This typically includes:
Your doctor will start by discussing your personal and family medical history, including any history of smoking or exposure to lung irritants. A physical examination will be performed to check for any physical signs of lung cancer.
These tests help visualize the lungs and detect any abnormalities:
A biopsy is essential to confirm the diagnosis and determine the specific type of NSCLC. Tissue samples can be obtained through various methods:
Blood tests and urine tests may be performed to check for general health status, identify markers associated with cancer, or rule out other conditions.
Treatment for NSCLC is highly individualized and depends on several factors, including the specific type of NSCLC, the stage of the cancer, the patient's overall health, and their personal preferences. Treatment often involves a combination of therapies:
Surgery is often the preferred treatment for early-stage NSCLC, aiming to remove the tumor and surrounding lymph nodes. Types of surgery include lobectomy (removing a lobe of the lung), pneumonectomy (removing an entire lung), or wedge resection (removing a small portion of the lung).
Radiation therapy uses high-energy rays to kill cancer cells or shrink tumors. It can be used as a primary treatment, before surgery to shrink tumors, after surgery to kill any remaining cancer cells, or to relieve symptoms.
Chemotherapy uses drugs to kill cancer cells throughout the body. It is often used for more advanced stages of NSCLC or in combination with other treatments.
Targeted therapy drugs focus on specific abnormalities (mutations) in cancer cells that help them grow and survive. These treatments are often more effective and have fewer side effects than traditional chemotherapy for patients with specific genetic mutations in their tumors.
Immunotherapy helps the body's own immune system recognize and fight cancer cells. It has become a significant advancement in NSCLC treatment, particularly for advanced stages.
While not all lung cancers can be prevented, the risk can be significantly reduced by adopting healthy lifestyle choices:
It is important to consult a doctor if you experience any persistent symptoms that could be indicative of lung cancer, especially if you have risk factors such as a history of smoking. Early detection significantly improves treatment outcomes and survival rates. Do not ignore symptoms like a chronic cough, chest pain, unexplained weight loss, or shortness of breath. Prompt medical evaluation is key.
Yes, while smoking is the leading cause, non-smokers can also develop NSCLC, particularly adenocarcinoma. Environmental factors, genetics, and exposure to secondhand smoke or other lung irritants can contribute.
The survival rate for NSCLC varies greatly depending on the stage at diagnosis and the specific type. The overall 5-year relative survival rate for NSCLC in India can be influenced by access to timely diagnosis and advanced treatments. Generally, survival rates are higher for localized cancers and lower for those that have spread. Advances in targeted therapy and immunotherapy have improved outcomes for many patients, even those with metastatic disease.
Early-stage NSCLC can often be cured with treatment, especially surgery. For more advanced stages, treatment focuses on controlling the cancer, managing symptoms, and improving quality of life. While a complete cure may not always be possible in advanced cases, significant progress has been made in extending survival and improving patient well-being.
The specific type of NSCLC (adenocarcinoma, squamous cell carcinoma, large cell carcinoma) influences treatment decisions. For example, certain genetic mutations common in adenocarcinoma may make patients eligible for targeted therapies. Squamous cell carcinoma might respond differently to certain chemotherapy or radiation regimens. Doctors use this information to tailor the most effective treatment plan.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026